AstraZeneca (AZN) declines to comment on M&A speculation - Bloomberg, citing spokesperson

October 17, 2016 10:48 AM EDT

Get instant alerts when news breaks on your stocks. Claim your 2-week free trial to StreetInsider Premium here.

AstraZeneca (NYSE: AZN) declines to comment on M&A speculation - Bloomberg, citing spokesperson



Serious News for Serious Traders! Try StreetInsider.com Premium Free!

You May Also Be Interested In






Related Categories

Mergers and Acquisitions, Trader Talk

Add Your Comment